SYNLOGIC, INC. Depreciation
SYNLOGIC, INC. (SYBX) reported Depreciation of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-12
- SYNLOGIC, INC. depreciation for the quarter ending 2025-12-31 was $0.00.
- SYNLOGIC, INC. depreciation for the quarter ending 2025-09-30 was $0.00.
- SYNLOGIC, INC. depreciation for the quarter ending 2025-06-30 was $0.00.
- SYNLOGIC, INC. depreciation for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. depreciation for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SYNLOGIC, INC. depreciation for fiscal 2024 was $347.00K, a 82.28% decline from fiscal 2023.
- SYNLOGIC, INC. depreciation for fiscal 2023 was $1.96M, a 22.30% decline from fiscal 2022.
- SYNLOGIC, INC. depreciation for fiscal 2022 was $2.52M, a 3.15% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $347.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $347.00K 10-Q · filed 2025-11-13 | $750.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $347.00K 10-Q · filed 2025-08-07 | $750.00K derived: sum of 3 quarters · filed 2025-08-07 | $1.20M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $347.00K 10-Q · filed 2025-05-08 | $750.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.20M derived: sum of 3 quarters · filed 2025-05-08 | $1.73M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $852.00K derived: sum of 2 quarters · filed 2025-03-06 | $1.38M derived: sum of 3 quarters · filed 2025-03-06 | $1.96M 10-K · filed 2025-03-06 |
| 2023-09-30 | $449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $979.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.55M 10-Q · filed 2024-11-12 | $2.17M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $530.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.11M 10-Q · filed 2024-08-08 | $1.72M derived: sum of 3 quarters · filed 2024-08-08 | $2.37M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $576.00K 10-Q · filed 2024-05-14 | $1.19M derived: sum of 2 quarters · filed 2024-05-14 | $1.84M derived: sum of 3 quarters · filed 2024-05-14 | $2.50M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $1.26M derived: sum of 2 quarters · filed 2024-03-19 | $1.92M derived: sum of 3 quarters · filed 2024-03-19 | $2.52M 10-K · filed 2024-03-19 |
| 2022-09-30 | $650.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.31M derived: sum of 2 quarters · filed 2023-11-09 | $1.91M 10-Q · filed 2023-11-09 | $2.52M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $656.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.26M 10-Q · filed 2023-08-10 | $1.87M derived: sum of 3 quarters · filed 2023-08-10 | $2.47M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $601.00K 10-Q · filed 2023-05-11 | $1.21M derived: sum of 2 quarters · filed 2023-05-11 | $1.81M derived: sum of 3 quarters · filed 2023-05-11 | $2.42M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $611.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.21M derived: sum of 2 quarters · filed 2023-03-29 | $1.82M derived: sum of 3 quarters · filed 2023-03-29 | $2.44M 10-K · filed 2023-03-29 |
| 2021-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.21M derived: sum of 2 quarters · filed 2022-11-10 | $1.83M 10-Q · filed 2022-11-10 | $2.48M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $606.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.23M 10-Q · filed 2022-08-11 | $1.89M derived: sum of 3 quarters · filed 2022-08-11 | $2.54M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $626.00K 10-Q · filed 2022-05-12 | $1.28M derived: sum of 2 quarters · filed 2022-05-12 | $1.94M derived: sum of 3 quarters · filed 2022-05-12 | $2.60M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $653.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.31M derived: sum of 2 quarters · filed 2022-03-17 | $1.97M derived: sum of 3 quarters · filed 2022-03-17 | $2.64M 10-K · filed 2022-03-17 |
| 2020-09-30 | $657.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.32M derived: sum of 2 quarters · filed 2021-11-10 | $1.98M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $659.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.33M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $667.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $2.70M 10-K · filed 2021-03-25 | |||
| 2018-12-31 | $632.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.23M derived: sum of 2 quarters · filed 2020-03-12 | $1.74M derived: sum of 3 quarters · filed 2020-03-12 | $2.42M 10-K · filed 2020-03-12 |
| 2018-09-30 | $597.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $1.11M derived: sum of 2 quarters · filed 2018-11-13 | $1.79M 10-Q · filed 2018-11-13 | $2.77M derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-06-30 | $511.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.19M 10-Q · filed 2018-08-09 | $2.18M derived: sum of 3 quarters · filed 2019-03-12 | $3.05M derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-03-31 | $681.00K 10-Q · filed 2018-05-15 | $1.67M derived: sum of 2 quarters · filed 2019-03-12 | $2.54M derived: sum of 3 quarters · filed 2019-03-12 | $2.77M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-12-31 | $986.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $1.86M derived: sum of 2 quarters · filed 2019-03-12 | $2.09M derived: sum of 3 quarters · filed 2019-03-12 | $2.31M 10-K · filed 2019-03-12 |
| 2017-09-30 | $870.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $1.10M derived: sum of 2 quarters · filed 2018-11-13 | $1.32M 10-Q · filed 2018-11-13 | $1.53M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $454.00K 10-Q · filed 2018-08-09 | $657.00K derived: sum of 3 quarters · filed 2018-08-09 | |
| 2017-03-31 | $222.00K 10-Q · filed 2018-05-15 | $425.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $692.00K 10-K · filed 2018-03-20 | ||
| 2016-09-30 | $489.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |